Regulation of cardiac fibroblast cellular function by leukemia inhibitory factor

被引:49
作者
Wang, F
Trial, J
Diwan, A
Gao, F
Birdsall, HH
Entman, ML
Hornsby, PJ
Sivasubramaniam, N
Mann, DL
机构
[1] Winters Ctr Heart Failure Res, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston VAMC, Huffington Ctr Aging, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston VAMC, Dept Otorhinolaryngol, Houston, TX 77030 USA
[4] Baylor Coll Med, Houston VAMC, Dept Med, Houston, TX 77030 USA
[5] Methodist Hosp, DeBakey Heart Ctr, Program Cardiovasc Sci, Houston, TX 77030 USA
关键词
cytokine; leukemia inhibitory factor; cardiac fibroblast; proliferation; differentiation; collagen content; MMP activity;
D O I
10.1006/jmcc.2002.2059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous studies have shown that leukemia inhibitory factor (LIF) provokes hypertrophic and cytoprotective effects in cardiac myocytes. However, the effects of LIF in cardiac fibroblasts are not known. Given that the cardiac fibroblast is the most abundant cell type in the heart, we sought to examine the functional effects of LIF on cardiac fibroblasts in vitro. Results: Short-term LIF stimulation (24 h) had no effect on fibroblast proliferation and/or cell differentiation. However. longer-term LIT stimulation (48-72 h) increased fibroblast proliferation, and significantly inhibited cardiac fibroblast differentiation into myofibroblasts. Moreover, 72 It of LIF stimulation significantly reduced collagen content in cardiac fibroblasts cultures, as well as decreased MMP activity in fibroblast culture supernatants. Conclusion: The results of this study suggest that LIF stimulation down-regulates several key components of the remodeling process, including collagen content and matrix metalloproteinase (MMP) activation, and thus suggest that LIF may play an important autocrine/paracrine role in preventing excessive extracellular matrix remodeling following acute myocardial injury. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:1309 / 1316
页数:8
相关论文
共 28 条
[1]   The deletion of transforming growth factor-β-induced myofibroblasts depends on growth conditions and actin organization [J].
Arora, PD ;
McCulloch, CAG .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :2087-2099
[2]   DEPENDENCE OF COLLAGEN REMODELING ON ALPHA-SMOOTH MUSCLE ACTIN EXPRESSION BY FIBROBLASTS [J].
ARORA, PD ;
MCCULLOCH, CAG .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 159 (01) :161-175
[3]   STIMULATION OF MYOBLAST PROLIFERATION IN CULTURE BY LEUKEMIA INHIBITORY FACTOR AND OTHER CYTOKINES [J].
AUSTIN, L ;
BURGESS, AW .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 101 (02) :193-197
[4]   Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations [J].
Coker, ML ;
Doscher, MA ;
Thomas, CV ;
Galis, ZS ;
Spinale, FG .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (02) :H777-H787
[5]  
DARBY I, 1990, LAB INVEST, V63, P21
[6]   Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation [J].
Denizot, Y ;
Lorgeot, V ;
Cornu, E ;
Nathan, N .
CYTOKINE, 1998, 10 (04) :303-306
[7]  
DESMOULIERE A, 1995, EXP NEPHROL, V3, P134
[8]  
EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183
[9]   DIFFERENTIAL-EFFECTS OF TRANSFORMING GROWTH FACTOR-BETA-1 AND PHORBOL-MYRISTATE ACETATE ON CARDIAC FIBROBLASTS - REGULATION OF FIBRILLAR COLLAGEN MESSENGER-RNAS AND EXPRESSION OF EARLY TRANSCRIPTION FACTORS [J].
EGHBALI, M ;
TOMEK, R ;
SUKHATME, VP ;
WOODS, C ;
BHAMBI, B .
CIRCULATION RESEARCH, 1991, 69 (02) :483-490
[10]   Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb) [J].
Frangogiannis, NG ;
Michael, LH ;
Entman, ML .
CARDIOVASCULAR RESEARCH, 2000, 48 (01) :89-100